Production (Stage)
Altamira Therapeutics Ltd.
CYTOF
$0.10
$0.00060.60%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 36.10% | 36.10% | 18.23% | 20.63% | 4,319.88% |
| Total Receivables | 295.16% | 295.16% | -86.23% | -85.95% | -89.22% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -98.11% | -98.11% | -82.03% | -81.67% | 58.61% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -65.40% | -65.40% | -5.11% | -3.21% | -45.69% |
| Total Current Assets | 5.99% | 5.99% | -72.89% | -72.35% | -24.02% |
|
|
|||||
| Total Current Assets | 5.99% | 5.99% | -72.89% | -72.35% | -24.02% |
| Net Property, Plant & Equipment | 372.58% | 372.58% | -3.62% | -1.72% | -80.25% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 0.00% | 0.00% | 6.34% | 8.45% | 9.88% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -5.37% | -5.37% | 16.39% | 18.70% | 34.14% |
|
|
|||||
| Total Accounts Payable | 6.91% | 6.91% | -76.01% | -75.53% | -90.48% |
| Total Accrued Expenses | 18.19% | 18.19% | -55.21% | -54.32% | -80.62% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3.38% | 3.38% | -95.09% | -94.99% | -7.14% |
| Total Finance Division Other Current Liabilities | -16.05% | -16.05% | -- | -- | -79.55% |
| Total Other Current Liabilities | -16.05% | -16.05% | -- | -- | -79.55% |
| Total Current Liabilities | 10.22% | 10.22% | -79.53% | -79.12% | -92.42% |
|
|
|||||
| Total Current Liabilities | 10.22% | 10.22% | -79.53% | -79.12% | -92.42% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -5.44% | -3.58% | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 66.08% | 66.08% | -86.42% | -86.15% | -72.68% |
| Total Liabilities | 42.14% | 42.14% | -80.48% | -80.10% | -90.71% |
|
|
|||||
| Common Stock & APIC | -99.96% | -99.96% | -99.97% | -99.97% | -88.54% |
| Retained Earnings | 85.80% | 85.80% | 105.67% | 105.79% | 90.20% |
| Treasury Stock & Other | 86.88% | 86.88% | 418.97% | 429.24% | 1,737.91% |
| Total Common Equity | -14.46% | -14.46% | 409.89% | 416.03% | 185.35% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -14.46% | -14.46% | 409.89% | 416.03% | 185.35% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -14.46% | -14.46% | 409.89% | 416.03% | 185.35% |
|
|
|||||